Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (91-100 of 666) with videos related to

Pageof 67
Sort By:
European Urology|November 8, 2017
Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65: Salvage Radiotherapy and Hormone Therapy: Change Is Coming, Just Not Quite YetDaniel E Spratt, Robert T Dess, Felix Y Feng
European Urology|January 24, 2019
Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy?Amar U Kishan, William A Hall, Daniel E Spratt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
End Point Definitions and Surrogacy in Prostate Cancer: Will Metastasis-Free Survival Become Event-Free Survival With Advances in Molecular Imaging?Robert T Dess, William C Jackson, Daniel E Spratt
Chemical Research in Toxicology|October 28, 2011
Tobacco-specific nitrosamine-derived O2-alkylthymidines are potent mutagenic lesions in SOS-induced Escherichia coliVijay P Jasti, Thomas E Spratt, Ashis K Basu
DNA Repair|July 17, 2010
Differential repair of polycyclic aromatic hydrocarbon DNA adducts from an actively transcribed geneQing Zhong, Shantu Amin, Philip Lazarus, et al.
Clinical Nuclear Medicine|November 27, 2008
I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancerTerence Z Wong, Manoj K Jain, Susan E Spratt
European Urology Focus|October 13, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography-guided RadiotherapyAmar U Kishan, Nicholas G Nickols, Daniel E Spratt
The Lancet. Oncology|March 9, 2017
Genomic-adjusted radiation doseDaniel E Spratt, Daniel R Wahl, Theodore S Lawrence
Journal of Analytical Toxicology|October 12, 1999
A fatality related to the veterinary anesthetic telazolC J Cording, R DeLuca, T Camporese, et al.
European Urology|July 12, 2023
Re: Dose-escalated Radiotherapy Alone or in Combination with Short-term Androgen Deprivation for Intermediate-risk Prostate Cancer: Results of a Phase III Multi-institutional TrialAngela Y Jia, Amar U Kishan, Daniel E Spratt
Pageof 67

Showing results (91-100 of 666) with videos related to

Sort By:
Pageof 67
European Urology|November 8, 2017
Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65: Salvage Radiotherapy and Hormone Therapy: Change Is Coming, Just Not Quite YetDaniel E Spratt, Robert T Dess, Felix Y Feng
European Urology|January 24, 2019
Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy?Amar U Kishan, William A Hall, Daniel E Spratt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
End Point Definitions and Surrogacy in Prostate Cancer: Will Metastasis-Free Survival Become Event-Free Survival With Advances in Molecular Imaging?Robert T Dess, William C Jackson, Daniel E Spratt
Chemical Research in Toxicology|October 28, 2011
Tobacco-specific nitrosamine-derived O2-alkylthymidines are potent mutagenic lesions in SOS-induced Escherichia coliVijay P Jasti, Thomas E Spratt, Ashis K Basu
DNA Repair|July 17, 2010
Differential repair of polycyclic aromatic hydrocarbon DNA adducts from an actively transcribed geneQing Zhong, Shantu Amin, Philip Lazarus, et al.
Clinical Nuclear Medicine|November 27, 2008
I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancerTerence Z Wong, Manoj K Jain, Susan E Spratt
European Urology Focus|October 13, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography-guided RadiotherapyAmar U Kishan, Nicholas G Nickols, Daniel E Spratt
The Lancet. Oncology|March 9, 2017
Genomic-adjusted radiation doseDaniel E Spratt, Daniel R Wahl, Theodore S Lawrence
Journal of Analytical Toxicology|October 12, 1999
A fatality related to the veterinary anesthetic telazolC J Cording, R DeLuca, T Camporese, et al.
European Urology|July 12, 2023
Re: Dose-escalated Radiotherapy Alone or in Combination with Short-term Androgen Deprivation for Intermediate-risk Prostate Cancer: Results of a Phase III Multi-institutional TrialAngela Y Jia, Amar U Kishan, Daniel E Spratt
Pageof 67